Thomas J. Farley net worth and biography

Thomas Farley Biography and Net Worth

Insider of Aditxt

From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant

How old is Thomas J. Farley?: Mr. Farley is currently 51 years old. There are 4 older executives and no younger executives at Aditxt. The oldest executive at Aditxt is Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D., Co-Founder, Chief Innovation Officer, Secretary & Director, who is 61 years old. Learn More on Thomas J. Farley's age.
How do I contact Thomas J. Farley?: The corporate mailing address for Mr. Farley and other Aditxt executives is 2569 WYANDOTTE ST. SUITE 101, MOUNTAIN CA, 94043. Aditxt can also be reached via phone at 650-870-1200 and via email at ir@aditxt.com. Learn More on Thomas J. Farley's contact information.
Has Thomas J. Farley been buying or selling shares of Aditxt?: Thomas J. Farley has not been actively trading shares of Aditxt during the last quarter. Most recently, on Wednesday, May 26th, Thomas J. Farley bought 0 shares of Aditxt stock. The stock was acquired at an average cost of $1,072,000.00 per share, with a total value of $0.00. Learn More on Thomas J. Farley's trading history.
Who are Aditxt's active insiders?: Aditxt's insider roster includes Thomas Farley (Insider), Corinne Pankovcin (CFO), and Shahrokh Shabahang (Insider). Learn More on Aditxt's active insiders.
Are insiders buying or selling shares of Aditxt?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 102 shares worth more than $29,835.00. The most recent insider tranaction occured on October, 16th when major shareholder Financial Lp Hrt sold 102 shares worth more than $29,835.00. Insiders at Aditxt own 0.0% of the company. Learn More about insider trades at Aditxt.
Information on this page was last updated on 10/16/2024.

Thomas J. Farley Insider Trading History at Aditxt

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/26/2021	Buy	0	$1,072,000.00	$0.00

Thomas J. Farley Buying and Selling Activity at Aditxt

Aditxt Company Overview

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Today's Range

Now: $4.52

$4.17

$4.91

50 Day Range

MA: $17.64

$4.37

$32.15

2 Week Range

Now: $4.52

$4.11

$54,500.00

Volume

159,901 shs

Average Volume

726,463 shs

Market Capitalization

$257,640.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27